Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
13 hedge funds and large institutions have $351K invested in Genetic Technologies Ltd. in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
18% more funds holding
Funds holding: 11 → 13 (+2)
42% less capital invested
Capital invested by funds: $607K → $351K (-$256K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$20.8K |
| 2 |
Renaissance Technologies
New York
|
+$16.2K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$13.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$10.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$9.53K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$170K |
| 2 |
CG
Cutler Group
San Francisco,
California
|
-$77 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $247K | +$16.2K | +1,050 | +5% |
|
|
2
Citadel Advisors
Miami,
Florida
| $27K | +$9.53K | +619 | +38% |
|
|
AGU
3
Alpine Group USVI
St. Thomas,
U.S. Virgin Islands
| $17K | – | – | – |
|
|
VF
4
Virtu Financial
New York
| $16K | +$20.8K | +1,354 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $15K | +$10.9K | +706 | +124% |
|
6
Cambridge Investment Research Advisors
Fairfield,
Iowa
| $10K | – | – | – |
|
|
OMC
7
Old Mission Capital
Chicago,
Illinois
| $10K | +$13.1K | +851 | New |
|
8
Jane Street
New York
| $6K | +$7.72K | +502 | New |
|
|
CG
9
Cutler Group
San Francisco,
California
| $3K | -$77 | -5 | -2% |
|
|
RE
10
RBC Europe
London,
United Kingdom
| $47 | – | – | – |
|
|
11
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$170K | -9,564 | Closed |
|
12
Morgan Stanley
New York
| – | +$15 | +1 | New |
|
GENE Hedge Fund Activity: Q2 2019 in Review
13 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q2 2019, worth a combined $351K — down 42% from $607K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new GENE positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $20.8K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $170K sold.
- 13 institutional investors held Genetic Technologies Ltd. (GENE) as of Q2 2019, up from 11 in Q1 2019.
- Funds reported $351K of Genetic Technologies Ltd. stock for Q2 2019, down 42% quarter-over-quarter.
- 4 funds opened new Genetic Technologies Ltd. positions in Q2 2019 and 2 closed out, a net change of +2 holders.
- The largest Genetic Technologies Ltd. buyer in Q2 2019 was Virtu Financial, an estimated $20.8K added.
- The largest Genetic Technologies Ltd. seller in Q2 2019 was Susquehanna International Group, an estimated $170K sold.
Based on aggregated 13F filings for Q2 2019.